Literature DB >> 14643886

Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia.

Maria Koter1, Ida Franiak, Karolina Strychalska, Marlena Broncel, Julita Chojnowska-Jezierska.   

Abstract

BACKGROUND: Hypercholesterolemia may decrease the deformability of red blood cells which impairs their hemorheological behavior and promotes atherosclerosis. The study involved 60 hypercholesterolemic patients and 30 healthy individuals as the control group.
METHODS: The membrane fluidity of erythrocytes was estimated by a spin-label method (5-doxylstearic acid (5-DSA)). The ratio of weakly to strongly (W/S) immobilized residues of erythrocyte membrane-bond maleimide-tempo spin label was studied in oxidative damage to membrane protein. Damage to erythrocyte proteins was also indicated by means of Na(+) K(+) ATPase activity.
RESULTS: The membranes of hyperlipidemia (hlp) patients contain larger concentrations of cholesterol 2.16+/-0.24 than do those of the normolipemic individuals 0.31+/-0.24 (P<0.001). The level of Na(+) K(+) ATPase in the erythrocyte membrane from the control group was higher 103.4+/-1.3 (nmolPi/(mgproteinsh)) than in the patient group 93.6+/-3.2 (nmolPi/(mgproteinsh)) (P<0.001). The order parameter S 5-DSA in the control group was 0.745+/-0.009 and in hlp patients was 0.755+/-0.009 (P<0.001). The W/S ratio in the control group amounted to 2.00+/-0.09 and in the hlp patient group was 2.50+/-0.11 (P<0.001).
CONCLUSION: Type-2 hypercholesterolemia causes changes in the structure and fluidity of erythrocyte plasma membranes since the excess of cholesterol affects the normal rheology of blood through its interaction with erythrocytes. It also impairs the function and structure of plasma membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14643886     DOI: 10.1016/s1357-2725(03)00195-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  19 in total

1.  Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population.

Authors:  Michael B Fessler; Kathryn Rose; Yanmei Zhang; Renee Jaramillo; Darryl C Zeldin
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 2.  Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine.

Authors:  Sooseong You; Bongki Park; Myeong Soo Lee
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia.

Authors:  Hüseyin Avni Uydu; Sermet Yıldırmış; Cihan Orem; Mustafa Calapoglu; Ahmet Alver; Birgül Kural; Asım Orem
Journal:  J Membr Biol       Date:  2012-06-16       Impact factor: 1.843

4.  eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.

Authors:  S Nagassaki; R D Herculano; C F O Graeff; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

5.  Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells.

Authors:  Rosie Dawaliby; Cataldo Trubbia; Cédric Delporte; Caroline Noyon; Jean-Marie Ruysschaert; Pierre Van Antwerpen; Cédric Govaerts
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

6.  In vivo influence of extract from Aronia melanocarpa on the erythrocyte membranes in patients with hypercholesterolemia.

Authors:  Piotr Duchnowicz; Agmieszka Nowicka; Maria Koter-Michalak; Marlena Broncel
Journal:  Med Sci Monit       Date:  2012-09

7.  Hypolipidemic and antioxidant effects of hydroxycinnamic acids, quercetin, and cyanidin 3-glucoside in hypercholesterolemic erythrocytes (in vitro study).

Authors:  Piotr Duchnowicz; Marlena Broncel; Anna Podsędek; Maria Koter-Michalak
Journal:  Eur J Nutr       Date:  2011-07-14       Impact factor: 5.614

8.  Oxidative damages in erythrocytes of patients with metabolic syndrome.

Authors:  A Ziobro; P Duchnowicz; A Mulik; M Koter-Michalak; M Broncel
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

9.  Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Authors:  Jiao Zheng; Binglin Liu; Qixing Lun; Weijuan Yao; Yunfang Zhao; Wei Xiao; Wenzhe Huang; Yonghua Wang; Jun Li; Pengfei Tu
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

10.  Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice.

Authors:  Lang Lei; Houxuan Li; Fuhua Yan; Yin Xiao
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.